Will COVID-19 and CMS’s Latest Stars Guidance be a Boom or Bust for MA plans? | Deloitte US
Explore the implications of CMS’s latest Stars guidance for Medicare Advantage plans.
Related Articles
Code Green: A podcast series
Listen to our Code Green podcast to hear insights from cyber leaders on the ways to combat threats within the life sciences and health care…
Smart Health Enterprise Model Could Enhance Patient Experiences, Outcomes
Can smart technologies improve the patient experience?
Digital talent acquisition is only half the battle on medtech’s path to digital maturity
Medtech companies should implement talent programs that meet their business and innovation objectives as well as their employees’ needs.
Proactive Steps May Help Pharma, Medtech Mitigate PFAS Risk
Deloitte offers framework for assessing PFAS risk.
The Impact of Social Connectedness on Health Outcomes
Explore the data behind the health benefits of socializing and how social and community networks impact health outcomes. Uncover strategies to help combat loneliness and…
Harnessing the Cloud Could Power AI Ambitions in Health Care
AI has transformative potential, but might need cloud to reach it.
Code Green: A podcast series
Listen to our Code Green podcast to hear insights from cyber leaders on the ways to combat threats within the life sciences and health care…
Capturing value from AI in business and health: Dbriefs webcast
May 8, 2024 | Join this Dbriefs to infer how AI capabilities are leading the way to transform the health care ecosystem.
Proactive Steps May Help Pharma, Medtech Mitigate PFAS Risk
Deloitte offers framework for assessing PFAS risk.
2024 Global Health Care Sector Outlook
How is AI being used to improve health care systems around the world?